Maravai LifeSciences Holdings Inc (NASDAQ: MRVI)’s stock price has plunge by -0.75relation to previous closing price of 2.02. Nevertheless, the company has seen a -3.14%
MRVI has 36-month beta value of 0.30. Analysts have mixed views on the stock, with 5 analysts rating it as a “buy,” 1 as “overweight,”
In the past week, MRVI stock has gone down by -7.98%, with a monthly decline of -34.47% and a quarterly plunge of -61.89%. The volatility
Moreover, the 36-month beta value for MRVI is 0.22. Analysts have varying opinions on the stock, with 5 analysts rating it as a “buy,” 1
The stock of Maravai LifeSciences Holdings Inc (MRVI) has gone down by -6.09% for the week, with a -28.48% drop in the past month and
The 36-month beta value for MRVI is at 0.13. Analysts have varying views on the stock, with 7 analysts rating it as a “buy,” 1
The 36-month beta value for MRVI is at 0.13. Analysts have varying views on the stock, with 7 analysts rating it as a “buy,” 1
Maravai LifeSciences Holdings Inc (NASDAQ: MRVI) has seen a decline in its stock price by -2.27 in relation to its previous close of 2.64. However,
© 2024, Powered by Smart TechOne
